CSJZX | PJEQX | CSJZX / PJEQX | |
Total Expense Ratio | 0.80 | 1.01 | 79% |
Annual Report Gross Expense Ratio | 0.83 | 1.01 | 82% |
Fund Existence | 6 years | 8 years | - |
Gain YTD | 5.091 | 1.921 | 265% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.76B | 149M | 5,208% |
Annual Yield % from dividends | 2.89 | 1.71 | 169% |
Returns for 1 year | 6.39 | 7.14 | 89% |
Returns for 3 years | 4.51 | 13.29 | 34% |
Returns for 5 years | 34.89 | 36.92 | 95% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FFEB | 53.43 | 0.20 | +0.38% |
FT Vest US Equity Buffer ETF Feb | |||
NJUL | 69.13 | 0.15 | +0.21% |
Innovator Nasdaq-100 Power Bfr ETF Jul | |||
RSF | 14.61 | 0.02 | +0.14% |
RiverNorth Capital and Income Fund | |||
HBMBF | 204.00 | N/A | N/A |
HBM Bioventures AG | |||
MIDE | 31.72 | -0.02 | -0.08% |
Xtrackers S&P MidCap 400 Scrd & Scrn ETF |